COVID-19 pushes Infectious Diseases in 2020

In 2020, investors invested millions in the development of vaccines and medications to fight the COVID-19 pandemic.

This is also reflected in our top 5 indications ranking by deal volume, where Infectious Diseases ranked 2nd, after Oncology.

About FCF Life Sciences

FCF Life Sciences advises leading healthcare companies in Europe on financing transactions (equity, debt, and licensing) with regional and international investors. Our team consists of science-driven industry and finance experts with a strong track record in managing financing processes. We thrive to maximize the efficiency in the fundraising process and increase its closing probability.

Learn more about FCF Life Sciences, click here.

We closely track the activity in the financial markets and are passionate about capital markets research. Not every idea or research question make it into the final selection for our publications. However, we generate interesting information on financing trends in Life Sciences sector, which we would like to share in our blog.

To hear from us on the latest insights, please sign up here: